Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
2.
Ann Ig ; 31(4): 333-348, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31268118

RESUMEN

INTRODUCTION: Co-infection of TB/ HIV is an emerging threat to a global public health. Although several studies have investigated the prevalence of TB/HIV co-infection in Iran, the results are inconsistent. The current systematic review and meta-analysis was planned to estimate the overall prevalence of TB/HIV co-infection in Iran. METHODS: Electronic databases, including MEDLINE (via PubMed), SCOPUS, SID and Mag Iran (two Persian scientific search engines) were searched up to 27 Apr 2017. The random effect model was used for estimating the prevalence of TB/ HIV co-infection. Heterogeneity was assessed by subgroup analysis. RESULTS: Forty-eight articles met our inclusion criteria, with a total of 21,388 individuals. The meta-analysis demonstrates that the prevalence of TB/ HIV co-infection in Iran was 14% [95% confidence interval CI:12-15%]. According to the meta-analysis of 5 subgroups, the prevalence of TB/ HIV co-infection in the subgroup with high intravenous drug users (IVDU) [27%, 95% CI: 20-35%], in border provinces of Iran [17%, 95% CI: 13-21%], in the subgroup with pulmonary tuberculosis (PTB) ≥ 20% [22%, 95% CI: 17-27%], in patients <40 years of age [25%, 95 CI: 19-31%] was significantly higher. There were no significant differences between the prevalence of co-infection among low and high-quality studies. Pulmonary TB was the predominant type of TB among co-infected patients [77%, 95% CI: 71 to 84%]. CONCLUSIONS: Our study demonstrates that the overall prevalence of TB/HIV co-infection in Iran was 14% [95% CI: 12-15%], which was a high rate. Some factors such as using intravenous drugs, living in border provinces of Iran, having PTB, and age <40 years had an impact on the prevalence of co-infection. Results revealed the need of HIV surveillance program among TB patients and screening of HIV-positive patients for diagnosis and treatment of TB. Further large-scale studies about the prevalence of this infection in all provinces of Iran are needed.


Asunto(s)
Infecciones por VIH/epidemiología , Tuberculosis Pulmonar/epidemiología , Tuberculosis/epidemiología , Adulto , Factores de Edad , Coinfección , Humanos , Irán/epidemiología , Prevalencia , Factores de Riesgo
3.
Minerva Med ; 106(4): 221-31, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25078329

RESUMEN

AIM: The aim of this study was to investigate the relationship between inter-individual global DNA methylation and diabetes predisposing factors. METHODS: The 5-methyl cytosine content was assessed by reverse phase high pressure liquid chromatography (RP-HPLC) of peripheral blood leukocytes obtained from 178 type 2 diabetes patients to determine individual global DNA methylation status. RESULTS: There was a positive significant correlation between diabetes duration and DNA methylation levels (P=0.002) with increasing levels of DNA methylation associated with age (P=0.047). There was no significant correlation between DNA methylation levels and HbA1c (P=0.15). No significant differences were observed between patients with and without diabetes predisposing factors including: hypertension (P=0.772), dyslipidemia (P=0.617), insulin resistance (homeostatic model assessment index) (P=0.156) and obesity (P=0.609). As such, the duration of diabetes (>10 years) was the most important predictor of global DNA methylation levels in diabetic patients after adjusting for age and sex (P=0.023). CONCLUSION: Our findings indicate that chronic hyperglycemic exposure plays an independent role in global DNA methylation levels in type 2 diabetes patients.


Asunto(s)
Cromatografía Líquida de Alta Presión , Metilación de ADN , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/diagnóstico , Albuminuria/orina , Biomarcadores/sangre , Índice de Masa Corporal , Estudios Transversales , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/orina , Progresión de la Enfermedad , Dislipidemias/complicaciones , Femenino , Hemoglobina Glucada/metabolismo , Humanos , Hipertensión/complicaciones , Leucocitos/metabolismo , Masculino , Persona de Mediana Edad , Obesidad/complicaciones , Valor Predictivo de las Pruebas , Reproducibilidad de los Resultados , Factores de Riesgo , Sensibilidad y Especificidad , Índice de Severidad de la Enfermedad
4.
Eur J Clin Microbiol Infect Dis ; 33(12): 2111-9, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24993150

RESUMEN

We conducted a systematic review and meta-analysis to evaluate the diagnostic potential of interleukin-2 (IL-2) as biomarkers for the diagnosis of latent tuberculosis. Related studies were identified through searches of PubMed, Embase, Web of Science, and complementary manual searches up to December 30, 2013. We used standard methods recommended for meta-analyses of diagnostic test evaluations. The analysis was based on a summary receiver operating characteristic (SROC) curve. Meta-regression analysis was used to assess the effects of some confounding factors on the results of the meta-analysis. The potential presence of publication bias was tested using the Deeks' funnel plots. The pooled estimates of IL-2 for latent tuberculosis infection (LTBI) diagnosis were as follows: sensitivity, 0.81 [95 % confidence interval (CI), 0.60 to 0.92]; specificity, 0.95 (95 % CI, 0.90 to 0.97); positive likelihood ratio (PLR), 15.2 (95 % CI, 8.1to 28.4); negative likelihood ratio (NLR), 0.20 (95 % CI, 0.09 to 0.47). We found that the SROC curve is positioned near the upper left corner of the curve and the area under the curve (AUC) was 0.96 (95 % CI, 0.94 to 0.98). In conclusion, according to the meta-analysis, IL-2 is a valid marker for the diagnosis of LTBI. When there is no definite gold standard for the diagnosis of LTBI, IL-2 release assay in addition to interferon-gamma release assays (IGRAs) can improve the ability of IGRAs to identify individuals with LTBI.


Asunto(s)
Pruebas Inmunológicas/métodos , Interleucina-2/sangre , Tuberculosis Latente/diagnóstico , Área Bajo la Curva , Biomarcadores/sangre , Humanos , Tuberculosis Latente/sangre , Tuberculosis Latente/inmunología , Curva ROC
5.
Spinal Cord ; 52(4): 322-6, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24296808

RESUMEN

OBJECTIVES: The present study was conducted to determine the prevalence of T-score discordance and its risk factors in a group of patients with spinal cord injury in a university teaching hospital in the Iranian capital of Tehran. METHODS: This cross-sectional study was conducted on paraplegic men undergoing bone density testing in an outpatient clinic at a hospital in the Iranian capital, Tehran, between March 2011 and 2012. A questionnaire on demographic and anthropometric characteristics, including age, height, weight, engagement in physical activity and personal smoking habits, was filled out for each subject. All the subjects underwent bone mineral density measurement and blood samples were sent for laboratory testing. RESULTS: Major T-score discordance between two sites was noted in 54 (41.22%) patients. Multivariate logistic regression revealed that every unit increase in serum calcium levels, as the only factor influencing T-score discordance, was associated with a 2.49-fold increased risk in T-score discordance in the area. As for the spine and radius, BMI was the only influencing factor as every unit increase in BMI was associated with a 14% lower risk for T-score discordance in these regions. Body mass index was the only factor, based on the multivariate model, affecting the risk of developing T-score discordance between two sites. CONCLUSION: Our study revealed the high prevalence of T-score discordance in patients with spinal cord injury. Physicians should therefore be encouraged to perform BMD at three sites when visiting patients with such injuries.


Asunto(s)
Densidad Ósea , Osteoporosis/diagnóstico , Osteoporosis/epidemiología , Paraplejía/epidemiología , Traumatismos de la Médula Espinal/epidemiología , Factores de Edad , Análisis Químico de la Sangre , Índice de Masa Corporal , Calcio/sangre , Estudios Transversales , Humanos , Irán/epidemiología , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Osteoporosis/metabolismo , Paraplejía/etiología , Paraplejía/metabolismo , Prevalencia , Traumatismos de la Médula Espinal/complicaciones , Traumatismos de la Médula Espinal/metabolismo
6.
East Mediterr Health J ; 17(2): 93-100, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21735942

RESUMEN

This study in 2006 estimated the hepatitis B virus (BHV) vaccination coverage in the Islamic Republic of Iran at the national and district levels in urban, rural and remote populations of 41 university health service areas. Of 21 905 children recruited to the study, vaccination coverage based on vaccination card records was 100% in 14, 15 and 10 of the 41 university areas for the 1st, 2nd and 3rd doses of HBV respectively. National levels of HBV1, HBV2 and HBV3 coverage were 98.9%, 98.8% and 98.4% respectively. The lowest HBV vaccination coverage rate was 90.7% (in a remote district). HBV vaccination coverage was at an acceptable level in Iranian children.


Asunto(s)
Vacunas contra Hepatitis B , Hepatitis B/prevención & control , Programas de Inmunización/estadística & datos numéricos , Preescolar , Femenino , Humanos , Lactante , Irán , Masculino , Servicios de Salud para Estudiantes
7.
(East. Mediterr. health j).
en Inglés | WHO IRIS | ID: who-118085

RESUMEN

This study in 2006 estimated the hepatitis B virus [BHV] vaccination coverage in the Islamic Republic of Iran at the national and district levels in urban, rural and remote populations of 41 university health service areas. Of 21 905 children recruited to the study, vaccination coverage based on vaccination card records was 100% in 14,15 and 10 of the 41 university areas for the 1st, 2nd and 3rd doses of HBV respectively. National levels of HBV1, HBV2 and HBV3 coverage were 98.9%, 98.8% and 98.4% respectively. The lowest HBV vaccination coverage rate was 90.7% [in a remote district]. HBV vaccination coverage was at an acceptable level in Iranian children


Asunto(s)
Vacunación , Encuestas y Cuestionarios , Vacunas contra Hepatitis B
8.
East Mediterr Health J ; 13(3): 560-6, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17687828

RESUMEN

We determined the rates of neural tube defects at a referral hospital in Gorgan, north Islamic Republic of Iran, and the relations of these abnormalities to sex, maternal ethnicity, maternal age and season. During 1998-2003, there were 109 cases among 37 951 births, a prevalence of 28.7 per 10000 (24.8 and 32.8 per 10 000 among males and females respectively). The rates in Turkmen, native Fars and Sistani ethnic groups were 40.5, 25.2 and 30.8 per 10 000 respectively. The rates of spina bifida and anencephaly were 16.3 and 11.3 per 10 000 respectively. The rate of affected newborns was highest in mothers aged over 35 years (50.7 per 10 000). The peak prevalence was in December.


Asunto(s)
Defectos del Tubo Neural/epidemiología , Adolescente , Adulto , Distribución de Chi-Cuadrado , Consanguinidad , Estudios Transversales , Emigración e Inmigración , Etnicidad , Femenino , Necesidades y Demandas de Servicios de Salud , Hospitales de Enseñanza , Humanos , Recién Nacido , Irán/epidemiología , Masculino , Edad Materna , Defectos del Tubo Neural/etiología , Vigilancia de la Población , Prevalencia , Sistema de Registros , Características de la Residencia , Factores de Riesgo , Estaciones del Año , Distribución por Sexo
9.
(East. Mediterr. health j).
en Inglés | WHO IRIS | ID: who-117283

RESUMEN

We determined the rates of neural tube defects at a referral hospital in Gorgan, north Islamic Republic of Iran, and the relations of these abnormalities to sex, maternal ethnicity, maternal age and season. During 1998-2003, there were 109 cases among 37 951 births, a prevalence of 28.7 per 10 000 [24.8 and 32.8 per 10 000 among males and females respectively]. The rates in Turkmen, native Fars and Sistani ethnic groups were 40.5, 25.2 and 30.8 per 10 000 respectively. The rates of spina bifida and anencephaly were 16.3 and 11.3 per 10 000 respectively. The rate of affected newborns was highest in mothers aged over 35 years [50.7 per 10 000]. The peak prevalence was in December


Asunto(s)
Defectos del Tubo Neural , Estudios Transversales , Prevalencia , Sistema Nervioso , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...